Checkmate raises $22M as Krieg hands off CEO role

Checkmate Pharmaceuticals Inc. (Cambridge, Mass.) said Wednesday it completed a $22 million extension of its series B round and hired Barry Labinger to succeed co-founder Arthur Krieg as president and CEO.

New investor Decheng Capital led Wednesday’s financing round, with participation from existing investors Sofinnova Ventures, venBio and F-Prime Capital. The new funds bring the round to $49 million...